abstract |
The present invention is in the field of medical chemistry. In particular, the present invention relates to a new class of small molecules having a quinazoline structure or quinoline structure that acts as a dual inhibitor of EGFR protein and PI3K protein, and their use as therapeutic agents for the treatment of cancer and other diseases. |